NCT03894215 2025-02-20RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical CancerAgenus Inc.Phase 2 Active not recruiting212 enrolled